BACKGROUND: The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS). METHODS: We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALS patients and 20 controls. RESULTS: Serum levels of anti-NFL were higher in ALS patients than in controls (P < 0.005). Serum anti-NFL antibodies and intrathecal anti-NFM antibodies were related to patient disability (serum anti-NFL: P < 0.05; intrathecal anti-NFM: P < 0.05). Anti-NFL levels were significantly correlated with anti-NFM levels in ALS (P < 0.001) and the control group (P < 0.0001) in the CSF, but not in serum. Anti-NFL and anti-NFM antibodies significantly correlated between serum and CSF in the ALS group (anti-NFL: P < 0.0001; anti-NFM: P < 0.001) and in the control group (anti-NFL: P < 0.05; anti-NFM: P < 0.05). CONCLUSIONS: Autoimmune humoral response to neurocytoskeletal proteins is associated with ALS.
BACKGROUND: The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS). METHODS: We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALSpatients and 20 controls. RESULTS: Serum levels of anti-NFL were higher in ALSpatients than in controls (P < 0.005). Serum anti-NFL antibodies and intrathecal anti-NFM antibodies were related to patient disability (serum anti-NFL: P < 0.05; intrathecal anti-NFM: P < 0.05). Anti-NFL levels were significantly correlated with anti-NFM levels in ALS (P < 0.001) and the control group (P < 0.0001) in the CSF, but not in serum. Anti-NFL and anti-NFM antibodies significantly correlated between serum and CSF in the ALS group (anti-NFL: P < 0.0001; anti-NFM: P < 0.001) and in the control group (anti-NFL: P < 0.05; anti-NFM: P < 0.05). CONCLUSIONS: Autoimmune humoral response to neurocytoskeletal proteins is associated with ALS.
Authors: Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis Journal: Transl Stroke Res Date: 2012-05-03 Impact factor: 6.829
Authors: Ching-Hua Lu; Corrie Macdonald-Wallis; Elizabeth Gray; Neil Pearce; Axel Petzold; Niklas Norgren; Gavin Giovannoni; Pietro Fratta; Katie Sidle; Mark Fish; Richard Orrell; Robin Howard; Kevin Talbot; Linda Greensmith; Jens Kuhle; Martin R Turner; Andrea Malaspina Journal: Neurology Date: 2015-05-01 Impact factor: 9.910
Authors: Caroline May; Eckhard Nordhoff; Swaantje Casjens; Michael Turewicz; Martin Eisenacher; Ralf Gold; Thomas Brüning; Beate Pesch; Christian Stephan; Dirk Woitalla; Botond Penke; Tamás Janáky; Dezső Virók; László Siklós; Jozsef I Engelhardt; Helmut E Meyer Journal: PLoS One Date: 2014-02-26 Impact factor: 3.240
Authors: Anna Häggmark; Maria Mikus; Atefeh Mohsenchian; Mun-Gwan Hong; Björn Forsström; Beata Gajewska; Anna Barańczyk-Kuźma; Mathias Uhlén; Jochen M Schwenk; Magdalena Kuźma-Kozakiewicz; Peter Nilsson Journal: Ann Clin Transl Neurol Date: 2014-07-14 Impact factor: 4.511
Authors: Maria Landqvist Waldö; Alexander Frizell Santillo; Ulla Passant; Henrik Zetterberg; Lars Rosengren; Christer Nilsson; Elisabet Englund Journal: BMC Neurol Date: 2013-05-29 Impact factor: 2.474
Authors: Ching-Hua Lu; Axel Petzold; Jo Topping; Kezia Allen; Corrie Macdonald-Wallis; Jan Clarke; Neil Pearce; Jens Kuhle; Gavin Giovannoni; Pietro Fratta; Katie Sidle; Mark Fish; Richard Orrell; Robin Howard; Linda Greensmith; Andrea Malaspina Journal: J Neurol Neurosurg Psychiatry Date: 2014-07-09 Impact factor: 10.154